中国铀业 20260226 摘要 中国铀业 2024 年天然铀总产量接近 4,000 吨铀，境外自产量约 2,200 吨铀，国内产量约 1,700 吨铀，占全球总产量约 6.4%，资源端优势显 著，拥有国内外多处矿产资源。 公司业务核心为自产天然铀，毛利占比超六成，放射性共伴生矿产资源 综合利用为附属板块，聚焦独居石、铀钼与钽铌等品类，各自产出氯化 稀土、四钼酸铵、五氧化二钽与五氧化二铌等产品。 随着"国铀 1 号"木头项目建成，预计公司权益量将增加约 1,500 吨， 总权益量达到约 4,500 吨左右，预计 2027 年铀矿自产量将实现翻倍， 该项目建设周期预计较招股书缩短。 需求端受益于中国机组落地、美国核电投资及日本重启核电，需求增速 预计 4%-5%；供给端受资本开支不足影响，新增量主要来自老矿复产， 供需矛盾推动铀价上涨，短期目标价位 106 美元/磅，长期看涨至历史 高点 136 美元/磅。 公司 2025 年上半年营收 96 亿元，净利 7.6 亿元；预计全年净利将近 17 亿元。天然铀产品销售收入占比 65%，毛利占比 84%。放射性共伴 生矿产资源综合利用业务营收占比 6.6%，毛利占比 ...

Investment Rating - The report assigns an "Outperform" rating for the company [4] Core Views - The company is a subsidiary of China National Nuclear Corporation, focusing on the comprehensive utilization of natural uranium and radioactive associated mineral resources [1][12] - The company plans to raise 4.4 billion yuan through its IPO, with 2.2 billion yuan allocated for natural uranium capacity projects and 700 million yuan for the comprehensive utilization of radioactive associated mineral resources [22] - The company is expected to produce 2,659 tons of U3O8 (equivalent to 2,255 tons of metal) from overseas sources in 2024, with an estimated domestic production of 1,700 tons, totaling 3,955 tons, which represents 6.4% of the global production of approximately 61,615 tons in 2024 [1][12] Summary by Sections Natural Uranium Business - The company has a dominant position in domestic natural uranium production, holding 17 mining rights for domestic natural uranium or uranium-molybdenum mines [1][59] - The natural uranium business is divided into self-produced uranium product sales, purchased uranium product sales, and international uranium trade [1][38] - The demand for natural uranium is expected to grow steadily, with supply constraints leading to a long-term bullish price outlook [1][39] Comprehensive Utilization of Radioactive Associated Mineral Resources - The company focuses on the comprehensive utilization of monazite, uranium-molybdenum, and tantalum-niobium [2] - The comprehensive utilization of monazite produces rare earth chlorides and sodium phosphate/carbonate as by-products, while uranium-molybdenum and tantalum-niobium processing yield ammonium paratungstate and tantalum/niobium oxides, respectively [2][27] Financial Forecast and Valuation - The company is projected to achieve net profits of 1.66 billion yuan, 3.49 billion yuan, and 4.87 billion yuan for the years 2025, 2026, and 2027, respectively, representing growth rates of 14%, 110%, and 40% [3][4] - The estimated reasonable valuation for the company is between 108.3 and 120.9 yuan, indicating a premium of 17% to 31% over the current stock price of 92.59 yuan [4]

Investment Rating - The report initiates coverage with a "Buy" rating and sets a target price of 80 CNY [5][11][15]. Core Insights - China Uranium Industry (001280) derives over 90% of its revenue from natural uranium business and is the exclusive supplier of natural uranium products for its controlling shareholder, China National Nuclear Corporation (CNNC) [2][11]. - The company is expected to benefit from the growing demand for nuclear energy and the ongoing global uranium supply-demand gap, which is projected to persist in the long term [11][39]. Financial Summary - The total revenue is projected to grow from 14,801 million CNY in 2023 to 31,422 million CNY by 2027, reflecting a compound annual growth rate (CAGR) of approximately 21.5% [4][16]. - Net profit attributable to the parent company is expected to increase from 1,262 million CNY in 2023 to 4,428 million CNY in 2027, with a significant growth rate of 87.8% in 2026 [4][11]. - Earnings per share (EPS) is forecasted to rise from 0.61 CNY in 2023 to 2.14 CNY in 2027 [4][11]. Revenue Breakdown - The revenue from natural uranium sales is expected to grow from 13,234.90 million CNY in 2023 to 28,500 million CNY by 2027, with a growth rate of 43.94% in 2024 [16]. - The radioactive co-mineral resource business is projected to see revenue growth from 1,164.08 million CNY in 2023 to 2,672.00 million CNY by 2027, with a notable increase of 39.51% in 2025 [16]. Industry Position - China Uranium Industry is a leading player in the uranium sector, with a strong historical presence and a comprehensive resource layout both domestically and internationally [19][24]. - The company controls significant uranium resources, ranking among the top ten global uranium producers, and has a robust operational footprint in key strategic areas [33][39]. Supply-Demand Dynamics - The global uranium market is characterized by a high concentration of resources, with the top five countries holding 68% of the total uranium reserves [39][40]. - The report highlights a persistent supply-demand gap in the uranium market, driven by increasing nuclear energy requirements and a recovery in global uranium production expected to reach 60,213 tons in 2024 [40][41].

Group 1 - The core viewpoint of the article is that the products tantalum pentoxide and niobium pentoxide produced by the company are important intermediate products in deep processing, with applications in various fields including steel, electronics, aerospace, medical, and superconductors [2] - The company indicated that the revenue contribution from tantalum and niobium oxides and their by-products is currently small, accounting for 1.04% of the company's main business revenue for the first half of 2025 [2]

Core Viewpoint - China Uranium Industry (001280.SZ) emphasizes its role in the natural uranium business, which includes mining, sales, and trading, highlighting the importance of natural uranium in nuclear energy and defense sectors [1] Group 1: Natural Uranium Business - The company's natural uranium products include uranyl sulfate and uranium trioxide [1] - Natural uranium is a critical material for the development of nuclear energy, utilized in nuclear power and national defense [1] Group 2: Radioactive Co-Product Resource Utilization - The company engages in the comprehensive utilization of radioactive co-products, including monazite, uranium-molybdenum, tantalum, and niobium [1] - Key products from this business include rare earth chloride, ammonium molybdate, tantalum pentoxide, and niobium pentoxide [1] - Rare earth chloride serves as a primary raw material for rare earth oxides, while ammonium molybdate is an important intermediate product in deep processing of molybdenum, mainly used in steel, metallurgy, and chemical industries [1] - Tantalum pentoxide and niobium pentoxide are significant intermediate products in the deep processing of tantalum and niobium, applied across various sectors including steel, electronics, aerospace, medical, and superconductors [1]

Group 1 - The company, Dongfang Tantalum Industry, confirmed its production capabilities related to niobium and tantalum compounds, which are essential for lithium niobate modulators used in high-speed optical interconnects [2] - The company is planning to use raised funds to construct a digital factory for tantalum and niobium wet metallurgy, which will include new production lines for potassium fluotantalate, niobium pentoxide, high-purity niobium pentoxide, high-purity tantalum pentoxide, and by-products such as tin concentrate [2]

Market Overview - The Shanghai Composite Index experienced narrow fluctuations around 3900 points, closing down 0.09% at 3894.22 points, while the Shenzhen Component Index and ChiNext Index fell by 0.19% and 0.5% respectively, with the Northbound 50 Index rising by 0.59% [1] - The total trading volume across the Shanghai, Shenzhen, and North exchanges reached 10,756 billion [1] Sector Performance - The real estate, semiconductor, and liquor sectors showed weakness, with over 3500 stocks declining [1] - The coal sector saw significant gains, with companies like Dayou Energy, Antai Group, and New Dazhou A hitting the daily limit, while Yunmei Energy rose approximately 6% [3][4] - The non-ferrous metals sector also performed well, with Huayang New Materials and Xinke Materials hitting the daily limit, and Tianshan Aluminum and Yun Aluminum rising over 5% [5] Diamond Industry - The cultivated diamond concept surged, with Sifangda rising nearly 15% and Huifeng Diamond increasing over 10% [7][8] - The diamond industry is focusing on functional applications, such as heat dissipation and optical window materials, which are expected to gain traction due to high demand from AI developments [9] China Uranium Industry - China Uranium (001280) debuted with a remarkable increase of 347%, reaching a peak of 80 yuan per share, and closed up 281.5% at 68.25 yuan per share, giving it a market capitalization exceeding 140 billion [11] - The company specializes in the comprehensive utilization of natural uranium and radioactive co-associated mineral resources, playing a crucial role in China's nuclear industry [11]

Market Overview - The Shanghai Composite Index experienced narrow fluctuations around 3900 points, closing down 0.09% at 3894.22 points, while the Shenzhen Component Index and ChiNext Index fell by 0.19% and 0.5% respectively [1] - The total trading volume in the Shanghai, Shenzhen, and Beijing markets reached 10,756 billion [1] - Over 3500 stocks declined, with sectors like real estate, semiconductors, and liquor showing weakness, while the coal sector saw gains [1] Coal Sector Performance - The coal sector showed strong performance, with companies like Dayou Energy, Antai Group, and New Dazhou A hitting the daily limit [4][5] - The prices of thermal coal and coking coal remain at historical lows, providing room for a rebound due to supply-side policies and seasonal demand increases [6] Nonferrous Metals Sector - The nonferrous metals sector also strengthened, with companies like Huayang New Materials and Xinke Materials hitting the daily limit, and Tianshan Aluminum and Yun Aluminum rising over 5% [7] - Analysts predict that the nonferrous metals industry is entering a new upward cycle, driven by supply chain disruptions and liquidity easing from the Federal Reserve [7] Cultivated Diamonds Concept - The cultivated diamond concept saw significant gains, with companies like Sifangda and Huifeng Diamond rising nearly 15% and over 10% respectively [9][10] - The diamond industry is focusing on functional applications, with potential growth in chip manufacturing due to high heat dissipation demands [11] China Uranium Industry - China Uranium Industry debuted with a remarkable increase of 347%, reaching a peak of 80 yuan per share, and closing up 281.5% at 68.25 yuan per share, with a market capitalization exceeding 1400 billion [12][13] - The company specializes in the comprehensive utilization of natural uranium and radioactive co-associated mineral resources, playing a crucial role in China's nuclear supply chain [13]

股票简称：中国铀业 股票代码：001280 中国铀业股份有限公司 China National Uranium Co., Ltd. （北京市通州区九棵树 145 号 26 幢 1 层） 首次公开发行股票并在主板上市 之上市公告书 保荐人（主承销商） （住所：北京市朝阳区安立路 66 号 4 号楼） 联席主承销商 （住所：广东省深圳市福田区中心三路 8 号卓越时代广场（二期）北座） 二〇二五年十二月 特别提示 中国铀业股份有限公司（以下简称"公司"、"本公司"、"发行人"、"中国铀业"） 股票将于 2025 年 12 月 3 日在深圳证券交易所主板上市。 本公司提醒投资者应充分了解股票市场风险及本公司披露的风险因素，在新股上市 初期切忌盲目跟风"炒新"，应当审慎决策、理性投资。 如无特别说明，本上市公告书中的简称或名词的释义与《中国铀业股份有限公司首 次公开发行股票并在主板上市招股说明书》（以下简称"招股说明书"）中的相同。如本 上市公告书中部分合计数与各单项数据之和在尾数上存在差异，这些差异是四舍五入所 致。 1 第一节 重要声明与提示 一、重要声明及提示 本公司及全体董事、高级管理人员保证上市公告书的真实性 ...

Core Viewpoint - The launch of China Uranium Corporation's IPO marks a significant milestone in the context of advancing global "dual carbon" goals and the rapid development of the domestic nuclear power industry, aiming to enhance the supply of natural uranium and solidify its strategic position as a leading technology-driven mining company [1][9]. Company Overview - China Uranium Corporation, a core subsidiary of China National Nuclear Corporation (CNNC), has evolved from its origins in 1989 to become a key player in the natural uranium supply chain, with a complete business structure encompassing mining, sales, and trade [2]. - The company holds 17 mining rights for natural uranium or uranium-molybdenum mines across resource-rich regions in China and has developed advanced extraction technologies to efficiently exploit complex sandstone uranium deposits [2][3]. Financial Performance - The company has shown robust growth, with revenue increasing from 10.535 billion yuan to 17.279 billion yuan from 2022 to 2024, reflecting a compound annual growth rate (CAGR) of 28.07%, while net profit rose from 1.520 billion yuan to 1.712 billion yuan during the same period [4]. - The natural uranium business remains the core revenue driver, contributing over 89% of total revenue in recent years, with projected revenue from this segment reaching 15.898 billion yuan in 2024 [4]. Investment and Growth Strategy - The IPO will raise funds primarily for enhancing natural uranium production capacity and the comprehensive utilization of radioactive co-mined resources, with a total investment plan of 4.798 billion yuan [7]. - Key projects include the development of several uranium mining operations in Inner Mongolia and Xinjiang, which are expected to significantly boost domestic uranium supply and reduce reliance on imports [7][10]. Market Demand and Opportunities - The global nuclear power industry is recovering, with a projected increase in uranium demand driven by the "dual carbon" goals, with estimates suggesting a rise to 86,000 tons by 2030 and 150,000 tons by 2040 [9][10]. - Domestically, China's nuclear power capacity is expected to grow significantly, with projections indicating an increase to approximately 12 million kilowatts by 2030, leading to a corresponding rise in uranium demand [10][11]. Policy Support - The Chinese government continues to strengthen support for strategic mineral resources, including uranium, as reflected in various policy documents that encourage the development of uranium mining and resource utilization technologies [11].